HA
Halberd Corporation
HALB · OTC
$0.00 +0.00% (+$0.00)
1M -7.78%
Market Cap $464.3K
P/E Ratio -
Div. Yield -
ROE 8.98%
Piotroski F-Score Weak
0/9Valuation
0 /100
Expensive P/S 464.75x
PEG N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 42.44%
Book val. growth N/A
EPS growth N/A
Profitability
0 /100
Weak Op. margin 7,512.51%
Gross margin 20.72%
FCF margin 5,169.17%
Quality
42 /100
Average ROA 786.46%
ROIC 13.20%
Asset turnover 0.10x
Debt
50 /100
Moderate Net debt/EBITDA -1.95x
Current ratio 0.01x
Int. coverage -16.22x
Stability
3 /100
Unstable EPS volatility 73.42%
Beta 0.13x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HALB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
William A. Hartman
Employees
3
Headquarters
Jackson Center